Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Optimization of post-filter ionized calcium target in continuous renal replacement therapy with regional citrate anticoagulation: a retrospective cohort study].

Created on 18 Nov 2026

Authors

Xiaoyuan Zhong, Jing Zhou, Yiyan Guo, Yu Zhang, Jiahuan Cheng, Yunjiao Ma, Huazhong Zhang, Xiangrong Zuo

Published in

Zhonghua wei zhong bing ji jiu yi xue. Volume 38. Issue 10. Pages 926-932.

Abstract

To investigate the impact of different levels of post-filter ionized calcium (pfCa2+) on filter lifespan and metabolic complications during regional citrate anticoagulation continuous renal replacement therapy (RCA-CRRT).
A retrospective cohort study was conducted. Patients who underwent RCA-CRRT in the intensive care unit (ICU) of The First Affiliated Hospital with Nanjing Medical University from April 2024 to May 2025 were enrolled. Based on the median of all pfCa2+ values during each RCA-CRRT session, sessions were divided into five groups: group A with 0.22 mmol/L≤pfCa2+ <0.30 mmol/L, group B with 0.30 mmol/L≤pfCa2+ <0.35 mmol/L, group C with 0.35 mmol/L≤pfCa2+≤0.40 mmol/L, group D with 0.40 mmol/L2+≤0.45 mmol/L, and group E with 0.45 mmol/L2+≤0.51 mmol/L. The primary outcome was filter lifespan, defined as the time from the start of RCA-CRRT to circuit termination due to filter clotting or elective replacement after 72 hours. The secondary outcome was the incidence of metabolic complications. A univariate Fine-Gray competing risk model was used for sensitivity analysis of filter lifespan. The 72-hour Kaplan-Meier curve for filter lifespan was plotted, and the 72-hour cumulative probability of filter remaining functional and the incidences of metabolic complications were compared among groups.
Initially, 261 RCA-CRRT sessions were screened. After excluding 10 sessions due to parameter changes, anticoagulation mode modifications, or >20% missing core data, a total of 251 sessions from 100 patients were enrolled. Among the 251 sessions, 170 (67.7%) were terminated due to filter clotting, 26 (10.4%) were discontinued for non-clotting reasons, and 55 (21.9%) were electively discontinued after reaching the 72-hour target. The numbers of sessions in groups A, B, C, D, and E were 17, 61, 118, 42, and 13, respectively. The citrate dose (citrate flow rate/blood flow rate) showed a decreasing trend as pfCa2+ increased (P<0.05), with the highest in group A [1.47 (1.27, 1.53)] and the lowest in group E [1.20 (1.10, 1.28)]. The median calcium gluconate infusion rate was 5 mL/h in all groups. The median sodium bicarbonate infusion rate was 30 mL/h in group B and 50 mL/h in the other group. The Fine-Gray competing risk model analysis showed that with the increase in pfCa2+, the cumulative incidence of filter clotting showed an upward trend (P<0.05), and the cumulative incidence was lower in both group B and group C than in group D (both P<0.05), and did not differ significantly between group B and group C (P>0.05). After excluding sessions with non-clotting discontinuations, 225 sessions were analyzed. The overall median filter lifespan was 56.5 (38.5, 71.3) hours. The number of sessions in groups A, B, C, D, and E were 17, 61, 118, 42, and 13, respectively, and the median filter lifespans were 58.3 (31.9, 72.0), 66.0 (52.0, 72.0), 58.5 (44.0, 71.0), 36.0 (22.5, 68.0), and 29.0 (17.0, 48.0) hours, respectively, with a statistically significant difference among groups (H=31.706, P<0.001). Groups B and C had significantly longer filter lifespans than groups D and E (all P<0.05). The Kaplan-Meier curves showed that the difference in 72-hour cumulative probability of filter remaining functional among the five groups was statistically significant (χ 2=31.822, P<0.001), which was higher in group B than in groups D and E, and higher in group C than in group E (all P<0.005), and no significant difference was found between group B and group C (P>0.005). Among metabolic complications, hyponatremia [41.0% (103/251)] and metabolic alkalosis [38.2% (96/251)] were the most common. The incidences of hypercalcemia, hyponatremia, and hypernatremia differed significantly among groups (all P<0.05). The highest incidence of hypercalcemia was observed in group B [19.7% (12/61)], and the highest incidence of hypernatremia was observed in group E [23.1% (3/13)]. Group C exhibited relatively low incidences of both hypercalcemia [5.9% (7/118)] and hypernatremia [1.7% (2/118)].
Maintaining pfCa2+ at 0.35-0.40 mmol/L during RCA-CRRT was associated with a relatively long filter lifespan and a lower incidence of metabolic complications, such as hypercalcemia and hypernatremia. This target range may represent a relatively ideal balance between filter lifespan and metabolic complications.

PMID:
43045523
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement